Coya Therapeutics logo

Coya Therapeutics Share Price Today

(NASDAQ: COYA)

Coya Therapeutics share price is $6.52 & ₹567.04 as on 6 Mar 2025, 2.30 'hrs' IST

$6.52

-0.27

(-3.98%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Coya Therapeutics share price in Dollar and Rupees. Guide to invest in Coya Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Coya Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Coya Therapeutics share price movements

  • Today's Low: $6.47
    Today's High: $6.87

    Day's Volatility :5.82%

  • 52 Weeks Low: $4.75
    52 Weeks High: $10.69

    52 Weeks Volatility :55.57%

Coya Therapeutics (COYA) Returns

PeriodCoya Therapeutics IncIndex (Russel 2000)
3 Months
9.03%
0.0%
6 Months
7.59%
0.0%
1 Year
-32.57%
0.0%
3 Years
42.67%
-11.6%

Coya Therapeutics (COYA) Key Statistics

in dollars & INR

Previous Close
$6.79
Open
$6.79
Today's High
$6.8699
Today's Low
$6.47
Market Capitalization
$113.4M
Today's Volume
$39.8K
52 Week High
$10.6899
52 Week Low
$4.75
Revenue TTM
$9.6M
EBITDA
$-11.1M
Earnings Per Share (EPS)
$-0.59
Profit Margin
-111.98%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-50.83%

How to invest in Coya Therapeutics Stock (COYA) from India?

It is very easy for Indian residents to invest directly in Coya Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Coya Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Coya Therapeutics or COYA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Coya Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Coya Therapeutics shares which would translate to 0.133 fractional shares of Coya Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Coya Therapeutics, in just a few clicks!

Returns in Coya Therapeutics (COYA) for Indian investors in Rupees

The Coya Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Coya Therapeutics investment value today

Current value as on today

₹72,374

Returns

₹27,626

(-27.63%)

Returns from Coya Therapeutics Stock

₹32,575 (-32.57%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Coya Therapeutics (COYA)

-79%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Coya Therapeutics Stock from India on INDmoney has decreased by -79% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Coya Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Coya Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Coya Therapeutics Stock (COYA)

What analysts predicted

Upside of 137.73%

Target:

$15.50

Current:

$6.52

Insights on Coya Therapeutics Stock (Ticker Symbol: COYA)

  • Price Movement

    In the last 3 months, COYA stock has moved up by 6.5%
  • COYA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 99.1%
  • Price to Sales

    ForCOYA every $1 of sales, investors are willing to pay $9.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Coya Therapeutics Technicals Summary

Sell

Neutral

Buy

Coya Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Coya Therapeutics (COYA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Coya Therapeutics Inc logo
4.82%
7.59%
-32.57%
42.67%
42.67%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Coya Therapeutics Inc logo
NA
NA
NA
-0.94
-0.51
-0.29
NA
2.1
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Coya Therapeutics Inc logo
Buy
$113.4M
42.67%
NA
-111.98%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Coya Therapeutics

Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It is developing COYA 101, an autologous regulatory T-cell product candidate that has completed Phase 2a clinical trial for use in the treatment of Amyotrophic Lateral Sclerosis. The company's product candidates in IND-enabling studies include COYA 301, a low-dose interleukin 2 Treg-enhancing biologic, which is in Phase 2 clinical trial for use in the treatment of Frontotemporal Dementia; and COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages for use in the treatment of neurodegenerative and autoimmune diseases. It is also developing COYA 201, an antigen directed Treg-derived exosome product candidate that is in preclinical stage for use in the treatment of neurodegenerative, autoimmune, and metabolic diseases; and COYA 206, an antigen directed Treg-derived exosome product candidate, which is in discovery stage. The company has a collaboration with Dr. Reddy's Laboratories SA for the development and commercialization of COYA 302, an investigational combination therapy for treatment of amyotrophic lateral sclerosis. The company was incorporated in 2020 and is headquartered in Houston, Texas.
Organization
Coya Therapeutics
Employees
8
CEO
Dr. Arun Swaminathan Ph.D.
Industry
Miscellaneous

Management People of Coya Therapeutics

NameTitle
Dr. Howard Berman Ph.D.
Executive Chair
Dr. Fred Grossman D.O., FAPA
President & Chief Medical Officer
Mr. David S. Snyder
CFO & COO
Dr. Arun Swaminathan Ph.D.
CEO & Director
Dr. Michelle Frazier Ph.D.
Senior Vice President of Regulatory Affairs
Mr. Aaron Thome Ph.D.
Head of Neuroinflammation Platform
Ms. Karen King M.S.
Senior VP of Program Management & Clinical Operations

Important FAQs about investing in COYA Stock from India :

What is Coya Therapeutics share price today?

Coya Therapeutics share price today stands at $6.52, Open: $6.79 ; Previous Close: $6.79 ; High: $6.87 ; Low: $6.47 ; 52 Week High: $10.69 ; 52 Week Low: $4.75.

The stock opens at $6.79, after a previous close of $6.79. The stock reached a daily high of $6.87 and a low of $6.47, with a 52-week high of $10.69 and a 52-week low of $4.75.

Can Indians buy Coya Therapeutics shares?

Yes, Indians can invest in the Coya Therapeutics (COYA) from India.

With INDmoney, you can buy Coya Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Coya Therapeutics at zero transaction cost.

How can I buy Coya Therapeutics shares from India?

It is very easy to buy Coya Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Coya Therapeutics (COYA) be purchased?

Yes, you can buy fractional shares of Coya Therapeutics with INDmoney app.

What are the documents required to start investing in Coya Therapeutics stocks?

To start investing in Coya Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Coya Therapeutics Stock (COYA)?

Today’s highest price of Coya Therapeutics (COYA) is $6.87.

Today’s lowest price of Coya Therapeutics (COYA) is $6.47.

What is today's market capitalisation of Coya Therapeutics?

Today's market capitalisation of Coya Therapeutics COYA is 113.4M

What is the 52 Week High and Low Range of Coya Therapeutics Stock (COYA)?

  • 52 Week High

    $10.69

  • 52 Week Low

    $4.75

What are the historical returns of Coya Therapeutics (COYA)?

  • 1 Month Returns

    4.82%

  • 3 Months Returns

    7.59%

  • 1 Year Returns

    -32.57%

  • 5 Years Returns

    42.67%

Who is the Chief Executive Officer (CEO) of Coya Therapeutics ?

Dr. Arun Swaminathan Ph.D. is the current Chief Executive Officer (CEO) of Coya Therapeutics.